切换至 "中华医学电子期刊资源库"
高级检索
中华产科急救电子杂志

中华产科急救电子杂志 ›› 2014, Vol. 03 ›› Issue (03) : 196 -199. doi: 10.3877/cma.j.issn.2095-3259.2014.03.012

所属专题： 文献；

论著

血浆置换在治疗妊娠期急性脂肪肝中的应用价值
王青青1, 白小艺1, 侯红瑛1,†()   
  1. 1. 510630　广州，中山大学附属第三医院产科
  • 收稿日期:2014-06-22 出版日期:2014-08-18
  • 通信作者: 侯红瑛
  • 基金资助:
    广东省科技计划项目(2009B060700107)

Clinical value of plasma exchange in treating patients with acute fatty liver of pregnancy

Qingqing Wang1, Xiaoyi Bai1, Hongying Hou1,†()   

  1. 1. Department of Obstetrics, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2014-06-22 Published:2014-08-18
  • Corresponding author: Hongying Hou
  • About author:
    Corresponding author: Hou Hongying, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

王青青, 白小艺, 侯红瑛. 血浆置换在治疗妊娠期急性脂肪肝中的应用价值[J]. 中华产科急救电子杂志, 2014, 03(03): 196-199.

Qingqing Wang, Xiaoyi Bai, Hongying Hou. Clinical value of plasma exchange in treating patients with acute fatty liver of pregnancy[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2014, 03(03): 196-199.

目的

探讨血浆置换在治疗妊娠期急性脂肪肝的中的应用价值。

方法

对2010年1月至2013年12月中山大学附属第三医院产科收治的17例采用血浆置换治疗妊娠期急性脂肪肝患者的临床资料进行回顾性分析，分析患者治疗前后的临床症状、体征、肝肾功能、凝血等指标，以及血浆置换出现的副作用。

结果

(1)患者治疗前后各项检查指标的比较：白细胞(20.2±9.1)×109/L与(15.2±5.9)×109/L、天冬氨酸转氨酶(304.3±312.6)U/L与(81.4±99.5)U/L、丙氨酸转氨酶(332.5±348.3)U/L与(116.7±198.9)U/L、总胆红素(130.5±113.6)μmol/L与(84.3±35.5)μmol/L、凝血酶原时间(22.5±6.3)s与(19.6±6.7)s、尿素(9.6±7.8) mmol/L与(7.6±4.2)mmol/L、尿酸(515.3±167.0)μmol/L与(380.0±219.4)μmol/L，均得到明显改善(P值均<0.05)；(2)血浆置换副作用小，未出现因不良反应而终止血浆置换治疗的病例。

结论

血浆置换用于治疗妊娠期急性脂肪肝具有安全、有效等特点，在及时终止妊娠后使用血浆置换可有效遏制病情的发展。

关键词: 脂肪肝, 急性病, 妊娠并发症, 血浆置换
Objective

To explore the application value of plasma exchange in treating acute fatty liver of pregnancy (AFLP).

Methods

This study collected the clinical data of 17 AFLP patients, who were treated with plasma exchange in the obstetrics department of The Third Affiliated Hospital of Sun Yat-sen University from January 2010 to December 2013. Symptoms, physical signs, hepatorenal function, coagulation function before and after treatment of plasma exchange and the adverse effects were retrospectively analyzed.

Results

(1) Compared with before treatment and after treatment, white blood cell, aspartate transaminase, alanine aminotransferase, total bilirubin, prothrombin time, urea and uric acid were obviously improved (P<0.05). Before treatment, white blood cell, aspartate transaminase, alanine aminotransferase, total bilirubin, prothrombin time, urea and uric acid were(20.2±9.1)×109/L, (304.3±312.6)U/L, (332.5±348.3)U/L, (130.5±113.6)μmol/L, (22.5±6.3)s, (9.6±7.8)mmol/L, (515.3±167.0)μmol/L, respectively. After treatment, they were (15.2±5.9)×109/L, (81.4±99.5)U/L, (116.7±198.9)U/L, (84.3±35.5)μmol/L, (19.6±6.7)s, (7.6±4.2)mmol/L, (380.0±219.4)μmol/L, respectively.(2) Adverse reactions during plasma exchange were generally mild and tolerable, and no patients discontinued treatment due to adverse events.

Conclusion

Plasma exchange is safe and effective for the AFLP patients, and timely application of plasma exchange after termination of pregnancy can effectively reverse the progression of AFLP.

Key words: Fatty Liver, Acute disease, Pregnancy complications, Plasma exchange
表1 17例AFLP患者血浆置换治疗前后实验室指标对比(±s)
组别 白细胞(×109/L) 天冬氨酸转氨酶(U/L) 丙氨酸转氨酶(U/L) 碱性磷酸酶(U/L) 谷氨酰转肽酶(U/L) 白蛋白(g/L) 总胆红素(μmol/L) 直接胆红素(μmol/L) 胆碱酯酶(U/L)
血浆置换前 20.2±9.1 304.3±312.6 332.5±348.3 359.4±164.5 105.5±54.0 26.1±3.9 130.5±113.6 97.4±61.0 3 261.8±1001.2
血浆置换后 15.2±5.9 81.4±99.5 116.7±198.9 183.1±107.8 73.5±45.5 29.2±3.0 84.3±35.5 47.1±43.2 4 690.7±1031.4
t值 2.544 3.539 4.880 5.337 2.341 －3.103 3.273 0.031 －2.438
P值 <0.05 <0.01 <0.01 <0.01 <0.05 <0.01 <0.05 <0.01 <0.05
组别 血糖(mmol/L) 凝血酶原时间(s) 凝血酶原活动度(%) 活化部分凝血活酶时间(s) 纤维蛋白原(g/L) 尿素(mmol/L) 肌酐(μmol/L) 尿酸(μmol/L)
血浆置换前 3.7±1.1 22.5±6.3 47.6±25.4 81.6±16.1 1.5±1.2 9.6±7.8 158.6±63.0 515.3±167.0
血浆置换后 5.8±1.2 19.6±6.7 71.2±27.6 52.8±13.2 2.8±0.9 7.6±4.2 106.6±18.4 380.0±219.4
t值 －2.346 2.762 －4.121 1.747 －2.268 －1.020 2.059 4.045
P值 <0.05 <0.05 <0.05 <0.05 <0.05 <0.05 >0.05 <0.01
[1]
曹泽毅. 中华妇产科学(临床版)[M]. 北京：人民卫生出版社，2010: 290-291.
[2]
Papafragkakis H, Singhal S, Anand S, et al. Acute fatty liver of pregnancy[J]. South Med J, 2013, 106(10):588-593.
[3]
Ch′ng CL, Morgan M, Hainsworth I, et al. Prospective study of liver dysfunction in pregnancy in Southwest Wales[J]. Gut, 2002, 51(6):876-880.
[4]
Tank PD, Nadanwar YS, Mayadeo NM, et al. Outcome of pregnancy with severe liver disease[J]. Int J Gynaecol Obstet, 2002, 76(1):27-31.
[5]
Holzman RS, Riley LE, Aron E, et al. Perioperative care of a patient with acute fatty liver of pregnancy[J]. Anesth Analg, 2001, 92(5):1268-1270.
[6]
Knight M, Nelson-Piercy C, Kurinczuk JJ, et al. A prospective national study of acute fatty liver of pregnancy in the UK[J]. Gut, 2008, 57(7):951-956.
[7]
Rajasri AG, Srestha R, Mitchell J, et al. Acute fatty liver of pregnancy (AFLP)--an overview[J]. J Obstet Gynaecol, 2007, 27(3):237-240.
[8]
Wei Q, Zhang L, Liu X, et al. Clinical diagnosis and treatment of acute fatty liver of pregnancy: a literature review and 11 new cases[J]. J Obstet Gynaecol Res, 2010, 36(4):751-756.
[9]
Martin JN Jr, Briery CM, Rose CH, et al. Postpartum plasma exchange as adjunctive therapy for severe acute fatty liver of pregnancy[J]. J Clin Apher, 2008, 23(4):138-143.
[10]
Tang W, Huang Z, Wang Y, et al. Effect of plasma exchange on hepatocyte oxidative stress, mitochondria function, and apoptosis in patients with acute fatty liver of pregnancy[J]. Artif Organs, 2012, 36(3):E39-47.
[11]
Jin F, Cao M, Bai Y, et al. Therapeutic effects of plasma exchange for the treatment of 39 patients with acute fatty liver of pregnancy[J]. Discov Med, 2012, 13(72):369-373.
[12]
Remiszewski P, Pawlak J, Skwarek A, et al. Orthotopic liver transplantation for acute liver failure resulting from " acute fatty liver of pregnancy" [J]. Ann Transplant, 2003, 8(3):8-11.
[13]
Westbrook RH, Yeoman AD, Joshi D, et al. Outcomes of severe pregnancy related liver disease: refining the role of transplantation[J]. Am J Transplant, 2010, 10(11):2520-2526.
[1] 谢晓宁, 王晓萍, 邵萍. 老年2型糖尿病患者非酒精性脂肪肝患病率及危险因素分析[J]. 中华危重症医学杂志(电子版), 2022, 15(04): 308-311.
[2] 杨皓媛, 龚杰, 邹青伟, 阮航. 哮喘孕妇的母婴不良妊娠结局研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 522-529.
[3] 高坎坎, 钟华敏, 谢永强, 邓秋连, 高飞, 王洁琳, 龙燕. 女性泌尿生殖道支原体感染及其耐药率分析[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(05): 569-576.
[4] 王思, 胡青, 廖华, 王晓东, 余海燕. 先天性生殖器官异常孕妇的围生结局分析[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(01): 87-93.
[5] 龚静, 张军. 晚孕期严重心脏病孕妇剖宫产术分娩同期心脏手术的可行性[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(01): 47-52.
[6] 张晋平, 朱志军, 孙丽莹, 魏林, 曲伟, 曾志贵, 张海明. 活体肝移植供肝脂肪变性评估研究进展[J]. 中华移植杂志(电子版), 2022, 16(04): 249-255.
[7] 孙克彦, 毛家玺, 刘业, 刘聪, 郭闻渊, 张磊, 滕飞. HBV相关性慢加急性肝衰竭等待肝移植患者血浆置换疗效影响因素[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 252-257.
[8] 李运林, 娄冬华. 滨海县非酒精性脂肪肝发病与消退的影响因素分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 354-358.
[9] 刘立业, 赵德芳. 非酒精性脂肪肝患者血清细胞因子信号转导抑制因子3、肝X受体α水平与CT影像学特征的相关性[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 211-215.
[10] 孔凡彪, 杨建荣. 肝脏基础疾病与结直肠癌肝转移之间关系的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(07): 818-822.
[11] 马文文, 呼敏, 王贵红, 高健. miR-103a-2、miR-122和vaspin在非酒精性脂肪性肝病合并HBV感染中的表达及意义[J]. 中华临床医师杂志(电子版), 2022, 16(02): 170-174.
[12] 陈真, 漆洪波. 易栓症与胎儿生长受限[J]. 中华产科急救电子杂志, 2023, 12(01): 18-21.
[13] 郎虓, 程蔚蔚. 妊娠期铁缺乏与贫血[J]. 中华产科急救电子杂志, 2022, 11(04): 202-207.
[14] 王晓娜, 白桂芹. 体外膜肺氧合技术在重症孕产妇救治中的应用[J]. 中华产科急救电子杂志, 2022, 11(02): 81-87.
[15] 何亚伟, 陈皖京, 宋佳宏, 于刚, 贾犇黎, 汪泳. 肥胖患者SCH、血清维生素D水平与NAFLD严重程度关系的研究[J]. 中华肥胖与代谢病电子杂志, 2023, 09(02): 95-101.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号